chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: 12 hours after redness and heat on hand and elbow on the left side; 12 hours after redness and heat on hand and elbow on the left side; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot unknown, first dose) solution for injection intramuscular in the left arm on 26Jan2021 at 07:30 (at the age of 36-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. There was no medical history. Concomitant medications included caffeine/paracetamol (EXCEDRIN), paracetamol (TYLENOL) and ergocalciferol (VIT D). Past drug history included known allergies: cefaclor (CECLOR) and sulfamethoxazole/trimethoprim (SEPTRA). The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 26Jan2021 at 19:30, 12 hours after vaccination, the patient experienced redness and heat on hand and elbow on the left side. Treatment included applied Burts Bees lotion on hand and elbow for the event redness and heat. The outcome of the event redness and heat was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: She felt fine aside from a sore arm at the site; This is a spontaneous report based on the information received by Pfizer from Merck & co, inc (Ref Case Number: 01838313). A contactable other healthcare professional reported for a female patient of unspecified age (her friend/nurse) received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter stated that her friend, who is a nurse, posted  on 06Jan2021 that she had gotten her first dose of the vaccine (date of administration unspecified) and then later in a text message said she felt fine aside from a sore arm at the site on an unspecified date. Outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm/arm felt sore; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: EL3247), via intramuscular route of administration, on 26Jan2021 10:15 AM (at the age of 28 years old) as a single dose in the left arm for COVID-19 immunization at work clinic. Relevant medical history were anxiety, depression. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN), aripiprazole (ABILIFY), iron, ascorbic acid (VITAMIN C). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Jan2021 at 04:00 PM, the patient experienced sore arm/arm felt sore. No treatment was received for the event arm/arm felt sore. The outcome of the event arm/arm felt sore was recovering. Since the vaccination, the patient had not been tested for COVID-19.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: Throbbing arm pain; Fever; Chills; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable healthcare professional (patient). A non-pregnant 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3248), intramuscular in left arm, on 18Dec2020 at 09:00 AM, at a single dose, for COVID-19 immunization. The patient's medical history included asthma, chronic back pain (surgery and scoliosis), migraines, systemic reaction to allergy injection, and COVID-19 in Jun2020 (prior vaccination). The patient's concomitant medications included pregabalin (LYRICA), butalbital, ascorbic acid (VITAMINS C), biotin, boron/ calcium/ Cimicifuga racemosa extract/ folic acid/ Glycine max extract/ Magnolia officinalis/ nicotinic acid/ pyridoxine hydrochloride/ riboflavin/ selenium/ thiamine/ tocopherol/ vitamin B12 NOS (ESTROVEN), Linum usitatissimum seed oil (FLAXSEED OIL), paracetamol (TYLENOL ARTHRITIS), and an unspecified stool softener and D (unspecified). The patient previously took amoxicillin and cinnamon oil and experienced allergies to both. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 18Dec2020 at 08:00 PM, the patient experienced throbbing arm pain for 2 days, fever, chills, body aches, headache, and fatigue for 2 days - some of the same symptoms she had when she had COVID-19 back in Jun2020. The events were considered non-serious. Treatment was received for the adverse events including ibuprofen, paracetamol (TYLENOL), and famotidine/ ibuprofen (DUEXIS). Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from "Throbbing arm pain" and "Fatigue" on 20Dec2020, and from the remaining events on an unspecified date.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Throbbing arm pain; Fever; Chills; Body aches; Headache; Fatigue; This is a spontaneous report from a contactable healthcare professional (patient). A non-pregnant 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3248), intramuscular in left arm, on 18Dec2020 at 09:00 AM, at a single dose, for COVID-19 immunization. The patient's medical history included asthma, chronic back pain (surgery and scoliosis), migraines, systemic reaction to allergy injection, and COVID-19 in Jun2020 (prior vaccination). The patient's concomitant medications included pregabalin (LYRICA), butalbital, ascorbic acid (VITAMINS C), biotin, boron/ calcium/ Cimicifuga racemosa extract/ folic acid/ Glycine max extract/ Magnolia officinalis/ nicotinic acid/ pyridoxine hydrochloride/ riboflavin/ selenium/ thiamine/ tocopherol/ vitamin B12 NOS (ESTROVEN), Linum usitatissimum seed oil (FLAXSEED OIL), paracetamol (TYLENOL ARTHRITIS), and an unspecified stool softener and D (unspecified). The patient previously took amoxicillin and cinnamon oil and experienced allergies to both. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 18Dec2020 at 08:00 PM, the patient experienced throbbing arm pain for 2 days, fever, chills, body aches, headache, and fatigue for 2 days - some of the same symptoms she had when she had COVID-19 back in Jun2020. The events were considered non-serious. Treatment was received for the adverse events including ibuprofen, paracetamol (TYLENOL), and famotidine/ ibuprofen (DUEXIS). Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from "Throbbing arm pain" and "Fatigue" on 20Dec2020, and from the remaining events on an unspecified date.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Feeling abnormal
Clinical narrative: she was "Just not feeling myself - nothing I can even describe in detail, just vaguely not myself; Did not want supper; This is a spontaneous report received from a non-contactable consumer (patient herself). A 78-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: Not available), via an unspecified route of administration on 23Jan2021 to 23Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient received any other medications within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient reported that on Monday (2 days post-vaccine on 25Jan2021) she was "Just not feeling myself - nothing, she can even describe in detail, just vaguely not myself. Did not want supper so had scrambled eggs and toast and went to bed early. Woke up feeling fine. She hardly ever felt other than fine and she could not think of anything other than the vaccine on Saturday that was unusual. On Sunday, she felt fine and today she feel fine". Treatment was not received for the events. The outcome of the events was recovered on Jan2021.  No follow-up attempts are possible; Information about lot/ batch number cannot be obtained.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: pt is a type 1 diabetic- increase in blood glucose above the norm despite insulin for a period of ~ 6hours; This is a spontaneous report from a non-contactable consumer. A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration at the age of 56 years on 26Jan2021 at a SINGLE DOSE for covid-19 immunisation .  Medical history included diabetes mellitus from an unknown date and unknown if ongoing type 1 diabetic. The patient's concomitant medications were not reported. The patient has a history of type 1 diabetes and had increase in blood glucose above the norm despite insulin for a period of 6hours on Jan2021. The patient underwent lab tests and procedures which included blood glucose: increase on Jan2021. No treatment was received for the event. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: I have a fever of 100.3, is that normal; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot unknown, first dose) solution for injection intramuscular on 26Jan2021 (at the age of 66-years-old) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. The patient stated, "I have a fever of 100.3 F, is that normal in Jan2021." The outcome of the event fever was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Cough, Fatigue
Clinical narrative: fever/Her dad was running a fever of a 102.9; tiredness; cough; headache; muscle pain; chills; joint pain; her father was feeling unwell; my dad was feeling nausea too; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's daughter) reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EL9262), via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that, caller mentioned that both her parents got the first dose of the COVID-19 vaccine and afterwards they got fever, tiredness, cough, headache, muscle pain, chills, joint pain, and her father was feeling unwell on an unspecified date in 2021. She wanted to know how many days do these side effect would last and also how to treat them. She was aware that this has been reported in the clinical trials. She has already got doctors but got no answers. This is the first case out of two cases. Transferring agent stated, "I have a caller on the line. She was calling about her parents. Her parents received the dose of Pfizer COVID vaccine on 20Jan2021. Her dad was running a fever of a 102.9 and her mother was running a fever of 101 on an unspecified date in 2021. So, she was kind of wondering how long this might last. I did give her the medical information department phone number, but I am getting her over to you to record the fever." When paraphrased the concern, reporter stated, "Yes, and what was the procedure to prevent it because they had the Pfizer vaccine and they have all the symptoms to them except not injection site redness and nausea. But my dad was feeling nausea too on an unspecified date in 2021." The outcome of the events was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Nausea, Pyrexia
Clinical narrative: fever/Her dad was running a fever of a 102.9; tiredness; cough; headache; muscle pain; chills; joint pain; her father was feeling unwell; my dad was feeling nausea too; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's daughter) reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EL9262), via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that, caller mentioned that both her parents got the first dose of the COVID-19 vaccine and afterwards they got fever, tiredness, cough, headache, muscle pain, chills, joint pain, and her father was feeling unwell on an unspecified date in 2021. She wanted to know how many days do these side effect would last and also how to treat them. She was aware that this has been reported in the clinical trials. She has already got doctors but got no answers. This is the first case out of two cases. Transferring agent stated, "I have a caller on the line. She was calling about her parents. Her parents received the dose of Pfizer COVID vaccine on 20Jan2021. Her dad was running a fever of a 102.9 and her mother was running a fever of 101 on an unspecified date in 2021. So, she was kind of wondering how long this might last. I did give her the medical information department phone number, but I am getting her over to you to record the fever." When paraphrased the concern, reporter stated, "Yes, and what was the procedure to prevent it because they had the Pfizer vaccine and they have all the symptoms to them except not injection site redness and nausea. But my dad was feeling nausea too on an unspecified date in 2021." The outcome of the events was unknown.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Vaccination site pain
Clinical narrative: Arm soreness at injection site; fatigue; slight muscle aches in neck/shoulders; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN 5318 and expiration date unknown), via an unspecified route of administration on left arm at the age of 54 years old on 26Jan2021 at 08:30 AM at a single dose for COVID-19 immunisation at the workplace clinic. Medical history included hypertension and pre-diabetic. Allergies to medications, food, or other products was none. Concomitant medications included metoprolol tartrate, atorvastatin and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient experienced arm soreness at injection site, fatigue, slight muscle aches in neck/shoulders on 26Jan2021 at 05:00 PM. The patient assessed the events as non-serious. No treatment was received in response to the events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient recovered from the events on an unspecified date in Jan2021.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Intranasal paraesthesia
Clinical narrative: nose felt tingly front teeth and right side of my tongue felt numb; nose felt tingly front teeth and right side of my tongue felt numb; This is a spontaneous report from a contactable consumer (patient herself). A 71-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL 9263), via an unspecified route of administration in left arm on 22Jan2021 16:15 at single dose for COVID-19 immunisation. The patient's medical history included diabetes, high cholesterol, thyroid, allergies: Sulfites in foods and drugs, allergies: Penicillin. Concomitant medications included metformin at 800 mg, twice a day and levothyroxine sodium (LEVOTHYROXIN) at 75mg, once a day. The patient previously took sulfur and experienced allergies: sulfur. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 22Jan2021, at 16:15, the patient reported nose felt tingly front teeth and right side of my tongue felt numb. The patient carries an epi pen for an allergic reaction as the patient have to sulfites in foods and drugs (sulfur and penicillin allergies). The patient did not have to call for help or use epi-pen but was concerned somewhat for the second dose in 19 days. The events was considered as non-serious by the consumer. When the patient went home about 15 minutes later still felt this, hence the therapeutic measures were taken as a result of events included treatment with 2tbl Benadryl and 1/2 Zertex and within 30 minutes the patient was ok. The outcome of the events was recovered on an unspecified date in Jan2021.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This is a spontaneous report from a contactable consumer, the patient. This 89-year-old female consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1 , single dose via unknown route of administration in the left arm on 25Jan2021 at 13:00 (at the age of 89 years-old)  for COVID-19 vaccination. Medical history included chronic obstructive pulmonary disease (COPD) diagnosed in 2016 and she never smoked in her life, it was second hand smoke, congestive heart failure diagnosed in 2015 and is hard of hearing several years back, she has had hearing aids for a long time, but they don't do any good. Concomitant medications included an unspecified flu shot. She was dizzy the night of 25Jan2021 and all day on 26Jan2021. The clinical outcome of dizzy was unknown.   Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Heart rate, Heart rate increased, Pain in extremity
Clinical narrative: sore arm; fast heartbeats like 110; weakness; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient experienced sore arm, fast heartbeats like 110, tightness, and weakness. Outcome of the sore arm was recovered on Jan2021 after 2 days while of the remaining events was unknown.  Information about batch/lot number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling hot, Muscle spasms, Retching
Clinical narrative: Lightheaded or dizzy; Dry heaves; Very warm; Charley horses in both legs; Chills; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3302), via an unspecified route of administration in right arm, on 26Jan2021 at 13:15 (01:15 PM), at a single dose, for COVID-19 immunization. The patient's medical history included chronic obstructive pulmonary disease (COPD). The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a doctor's office or urgent care facility. On 26Jan2021 (reported as 12:15 AM; pending clarification), the patient woke up lightheaded or dizzy, with dry heaves, very warm, and with Charley (reported as Charlie) horses in both legs, then she got the chills. This morning (27Jan2021), the patient felt fine. No treatment was administered for the adverse events. The patient was not tested for COVID-19 post vaccination. The patient recovered from the events on 27Jan2021.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Sleep terror
Clinical narrative: Exhausted; Night terrors; This is a spontaneous report from a contactable consumer, the patient. This 51year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3248), DOSE 1, single dose via unknown route of administration in the left arm on 25Jan2021 about 3:45pm (at the age of 51 years-old)  for COVID-19 vaccination. Medical history included ongoing severe asthmatic onset date unknown, probably during childhood but worsened with age and became really bad after hurricane, ongoing irregular heartbeat, ongoing menopause, ongoing food allergies includes banana peppers, jalepenos and nuts; anything spicy; these cause anaphylactic reactions where her throat is itching and swells, ongoing Hashimoto's disease, thyroid, endocrine abnormality and compromises immune system, to keep her brain going through menopause, seizure disorder and high blood pressure. Past drug events included Demerol-Vistaril: ate part of her leg away, top layer of her leg just fell off; she had all the skin done and had plastic surgery to repair this in 1988; Lot/NDC/Expiry: Unknown, does not have product, anaphylactic reactions to: penicillin: Lot/NDC/Expiry: Unknown, does not have product; clindamycin: Lot/NDC/Expiry: Unknown, does not have product; sulfa: Lot/NDC/Expiry: Unknown, does not have product; Darvocet: Lot/NDC/Expiry: Unknown, does not have product; Ceclor: Lot/NDC/Expiry: Unknown, does not have product. There was no family medical history relevant to events, night terrors  and exhausted. Concomitant medications included atenolol 12.5mg taken once daily (1/2 of 25mg tablet) for irregular heartbeat, levothyroxine 125mcg taken once daily for thyroid,  bupropion (WELLBUTRIN) 300mg taken once daily for menopause, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) 20mg extended release taken once daily to keep her brain going through menopause, topiramate (TOPAMATE) 25mg taken once daily for seizure disorder and lisinopril 10mg taken daily for high blood pressure.  On 26Jan2021, the patient had night terrors where she started screaming in her sleep at midnight and was exhausted at 05:00 and ongoing. There were no relevant tests. The night terrors and exhausted did not require a visit to the physician's office or emergency room. The clinical outcome of night terrors was recovered with sequel and  not recovered for exhausted. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available): None.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness at injection site; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received the first dose on 14Jan2021. It was reported that the patient experienced redness at injection site on an unspecified date and it maintains. The patient asked if she should get it in opposite arm on 04Feb2021. The outcome of event was not recovered.  Information on lot/batch has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body height, Body height decreased, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: redness at injection site; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received the first dose on 14Jan2021. It was reported that the patient experienced redness at injection site on an unspecified date and it maintains. The patient asked if she should get it in opposite arm on 04Feb2021. The outcome of event was not recovered.  Information on lot/batch has been requested.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: his arm is starting to sore.; arm started getting sore where he received the injection; This is a spontaneous report from Pfizer via a contactable consumer (mother). A 69-year old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (at the age of 69-years-old), via an unspecified route of administration on 25Jan2021 as a single dose for covid-19 immunization.  The patient has no medical history and Is not taking any concomitant medications. On 25Jan2021, he experienced his arm is starting to sore and about an hour after that his arm started getting sore where he received the injection. He states that he took two Tylenol and by the next morning his arm was feeling totally better. He states that he had no other symptoms. The clinical outcome of the event his arm started getting sore was recovering; the outcome of sore where he received the injection was unknown.  Information on Lot/Batch has been requested.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Hypoaesthesia
Clinical narrative: Chest pain and pressure; Chest pain and pressure; Numbness on left jaw, arm and hand; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 71-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration in right arm on 23Jan2021 13:45 at single dose for COVID-19 immunisation in facility type other. The patient's medical history included asthma, unspecified auto immune, sickle cell trait, reflux. The patient have allergies to medications, food, or other products. Concomitant medications included nifedipine (CELEBRATE) at 200 mg, mirtazapine at 7.5 mg, vitamin b12, ascorbic acid (VITAMIN C). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 23Jan2021 04:00 AM, the patient experienced chest pain and pressure, numbness on left jaw, arm and hand. The adverse events result in emergency room/department or urgent care. The events were considered as non-serious by the other healthcare professional. The patient did not receive treatment for the adverse events. The outcome of the events was recovering.   Information on the lot/batch number has been requested.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, SARS-CoV-2 test
Clinical narrative: lost taste and smell; lost taste and smell; This is a spontaneous report from a contactable nurse (patient herself). A 52-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 04Jan2021 10:45, at single dose, for covid-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), on an unspecified date, at single dose, for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The vaccine was administered in the hospital. 3 weeks after the 2nd dose, on 27Jan2021 the patient lost taste and smell. Her PCR nasal Covid swab was negative on 27Jan2021. The patient had not recovered from the adverse events. No treatment was received for the adverse events.  Information about the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in the injection site/a little bit of pain at the injection site; This is a spontaneous report from a contactable consumer (patient) via the Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown) on an unspecified date then the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), on 24Jan2021 - both via an unspecified route of administration, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient just received the 2nd dose of the Covid-19 Vaccine yesterday morning (also reported as around noon time), 24Jan2021. The patient stated she was fully aware of the other side effects, but she was not experiencing those other than pain in the injection site on Jan2021. She added she was not experiencing any of the effects that she was told that she should and with other people she knew who have gotten the vaccine that they have. The only thing that she had was a little bit of pain at the injection site which was what she also had on an unspecified date after the first shot on an unspecified date. She stated she had nothing, no fever, no chills, no headache; nothing that they said she should be experiencing. She then asked if that meant it was not working. She wanted to know more information about herself and if she was immune to those. The outcome of the event was unknown.  Information about the lot/batch number has been requested.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Headache, Nausea
Clinical narrative: Throwing up; vomited 4 times; Chills; Headache; Fever; highest temperature was 101.4 degrees; low-grade temperature; Nausea; Stomach was not feeling right; upset stomach; This is a spontaneous report from a contactable consumer (patient's mother who is a caregiver). An 18-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), intramuscular in right arm, on 26Jan2021 at 07:30, at a single dose, for COVID-19 immunization. The patient's medical history included birth control pill. The patient's concomitant medication included ethinylestradiol/ norgestrel (CRYSELLE) from 26Jan2021 as birth control pill. The patient previously took the first dose of BNT162B2 on 05Jan2021 at 08:00 AM for COVID-19 immunization (in right arm). The vaccine was administered in a hospital facility. The patient was a certified nursing assistant (CNA) at a hospital. The patient and her mother both work at the same hospital that administered their COVID-19 vaccines, both received the first and second COVID-19 vaccines at the same date and time. The patient received her second COVID-19 vaccine dose yesterday (26Jan2021). Since 26Jan2021 around 09:00 PM, the patient was experiencing symptoms of chills, headache, fever, and nausea. The patient had a fever, clarifying that the highest temperature was 101.4 degrees, and also has chills and headache. Last night (26Jan2021 at 09:00 PM), the patient's stomach was not feeling right, had a low-grade temperature, and chills. On this morning (27Jan2021), the patient was throwing up. The patient didn't throw up until this morning and has vomited 4 times today. The patient has not sought medical treatment from an emergency room or doctor yet. The patient has been throwing up today. If the patient continues throwing up, and becomes dehydrated, she may need to go the emergency room. It was also reported that the patient started ethinylestradiol/ norgestrel last night. The patient's mother thought that the patient's initial stomach upset may have been caused by the ethinylestradiol/ norgestrel. Therapeutic measures were taken as a result of headache and fever including ibuprofen and acetaminophen; the patient isn't taking anything for nausea at this time. The patient's mother wanted to see if anyone else had been reporting these side effects the patient has been experiencing since receiving her second COVID-19 vaccine dose. The patient had not recovered from the events.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Throwing up; vomited 4 times; Chills; Headache; Fever; highest temperature was 101.4 degrees; low-grade temperature; Nausea; Stomach was not feeling right; upset stomach; This is a spontaneous report from a contactable consumer (patient's mother who is a caregiver). An 18-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), intramuscular in right arm, on 26Jan2021 at 07:30, at a single dose, for COVID-19 immunization. The patient's medical history included birth control pill. The patient's concomitant medication included ethinylestradiol/ norgestrel (CRYSELLE) from 26Jan2021 as birth control pill. The patient previously took the first dose of BNT162B2 on 05Jan2021 at 08:00 AM for COVID-19 immunization (in right arm). The vaccine was administered in a hospital facility. The patient was a certified nursing assistant (CNA) at a hospital. The patient and her mother both work at the same hospital that administered their COVID-19 vaccines, both received the first and second COVID-19 vaccines at the same date and time. The patient received her second COVID-19 vaccine dose yesterday (26Jan2021). Since 26Jan2021 around 09:00 PM, the patient was experiencing symptoms of chills, headache, fever, and nausea. The patient had a fever, clarifying that the highest temperature was 101.4 degrees, and also has chills and headache. Last night (26Jan2021 at 09:00 PM), the patient's stomach was not feeling right, had a low-grade temperature, and chills. On this morning (27Jan2021), the patient was throwing up. The patient didn't throw up until this morning and has vomited 4 times today. The patient has not sought medical treatment from an emergency room or doctor yet. The patient has been throwing up today. If the patient continues throwing up, and becomes dehydrated, she may need to go the emergency room. It was also reported that the patient started ethinylestradiol/ norgestrel last night. The patient's mother thought that the patient's initial stomach upset may have been caused by the ethinylestradiol/ norgestrel. Therapeutic measures were taken as a result of headache and fever including ibuprofen and acetaminophen; the patient isn't taking anything for nausea at this time. The patient's mother wanted to see if anyone else had been reporting these side effects the patient has been experiencing since receiving her second COVID-19 vaccine dose. The patient had not recovered from the events.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Rash macular
Clinical narrative: she experienced hand and feet itching/her arm is itchy; she noticed red streaks and splotches going up her arm to her elbows; she noticed red streaks and splotches going up her arm to her elbows; her arm started stinging; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she received the first dose of the vaccine on 13Jan2021 and after the vaccine, she experienced hand and feet itching that lasted a few days in Jan2021. On Thursday and Friday after receiving the vaccine, she took Benadryl and put Cortisone on her hands. She then went to her doctor who prescribed her a medication and the Pharmacist told her it was Benadryl. She took the medication for 5 days and the medication stopped the itching. Today (as reported), her hands were itchy and she noticed red streaks and splotches going up her arm to her elbows and her arm was itchy, in Jan2021. Her arm started stinging as well while working at the dentist office today (as reported). Patient would like to know if she should receive the second dose as she was scheduled to receive the second dose on 03Feb2021. Outcome of events was unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Erythema, Pain in extremity, Pruritus, Vaccination site erythema
Clinical narrative: she experienced hand and feet itching/her arm is itchy; she noticed red streaks and splotches going up her arm to her elbows; she noticed red streaks and splotches going up her arm to her elbows; her arm started stinging; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she received the first dose of the vaccine on 13Jan2021 and after the vaccine, she experienced hand and feet itching that lasted a few days in Jan2021. On Thursday and Friday after receiving the vaccine, she took Benadryl and put Cortisone on her hands. She then went to her doctor who prescribed her a medication and the Pharmacist told her it was Benadryl. She took the medication for 5 days and the medication stopped the itching. Today (as reported), her hands were itchy and she noticed red streaks and splotches going up her arm to her elbows and her arm was itchy, in Jan2021. Her arm started stinging as well while working at the dentist office today (as reported). Patient would like to know if she should receive the second dose as she was scheduled to receive the second dose on 03Feb2021. Outcome of events was unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment
Clinical narrative: she experienced hand and feet itching/her arm is itchy; she noticed red streaks and splotches going up her arm to her elbows; she noticed red streaks and splotches going up her arm to her elbows; her arm started stinging; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she received the first dose of the vaccine on 13Jan2021 and after the vaccine, she experienced hand and feet itching that lasted a few days in Jan2021. On Thursday and Friday after receiving the vaccine, she took Benadryl and put Cortisone on her hands. She then went to her doctor who prescribed her a medication and the Pharmacist told her it was Benadryl. She took the medication for 5 days and the medication stopped the itching. Today (as reported), her hands were itchy and she noticed red streaks and splotches going up her arm to her elbows and her arm was itchy, in Jan2021. Her arm started stinging as well while working at the dentist office today (as reported). Patient would like to know if she should receive the second dose as she was scheduled to receive the second dose on 03Feb2021. Outcome of events was unknown.  Information on the batch/lot number has been requested.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Fatigue
Clinical narrative: moderate fatigue/tiredness; some difficulty concentrating; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL 3247, expiry date unknown) in the workplace clinic, via an unspecified route of administration on 26Jan2021 at 13:45 at a single dose on the left arm for COVID-19 immunization. The patient had no medical history and no known allergies. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. It was reported that on 27Jan2021 at 06:45, the morning after the patient was vaccinated, he had moderate fatigue/tiredness with some difficulty concentrating. The patient stated that it felt similar to getting 2-3 hour sleep, but he had no issue sleeping last night. The patient did not receive treatment for the event. The patient was recovering from the events.  The events were reported as non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: migraine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter wanted to know if the patient could take Sudafed PE for a migraine that she was experiencing from an unspecified date. The patient received the first dose of the vaccine yesterday afternoon (26Jan2021), in which her doctor recommended her to not take ibuprofen within the first 24 hours of the vaccine. The outcome of event was unknown.  Information about lot/batch number has been requested.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Headache, Nausea, SARS-CoV-2 test
Clinical narrative: Loss of taste and smell; Loss of taste and smell; nausea; headache; This is a spontaneous report from a contactable nurse (patient himself). A 32-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscularly on the left arm on 25Jan2021, at single dose, for covid-19 immunization. The patient has no medical history and has no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number known but not reported) on an unspecified date for covid-19 immunization. The patient experienced loss of taste and smell, nausea, and headache - all on 26Jan2021. No treatment was received for the adverse events. At the time of the report, the patient had not recovered from the adverse events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination. The patient had a nasal swab for Covid-19 on 26Jan2021 with results of negative.  Information about the lot/batch number has been requested.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Sore arm at the injection site; Exhaustion; Achy body; Low-grade fever; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL8982 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 26Jan2021 14:30 at single dose for Covid-19 immunization administered at Hospital. The patient's medical history Have a stent in my heart, mild heart attack 2+ years ago, and Covid-19. The patient's concomitant medication included acetylsalicylic acid (BABY ASPIRIN) at 83 mg, metoprolol, and evolocumab (REPATHA). On 26Jan2021 21:30, the patient experienced Sore arm at the injection site, exhaustion, achy body, low-grade fever. The patient did not received treatment for the events. The reporter assessed the events as non-serious. The outcome of the events was recovering. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Influenza like illness
Clinical narrative: Experienced flu-like symptoms and a temperature of 102 the evening after receiving the second dose of the COVID-19 vaccine; Experienced flu-like symptoms and a temperature of 102 the evening after receiving the second dose of the COVID-19 vaccine; This is a spontaneous report from a contactable consumer via Pfizer Sales Representative. A 39-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration at the age of 39 years, on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced flu-like symptoms and a temperature of 102 the evening after receiving the second dose of the COVID-19 vaccine on an unspecified date. The patient underwent lab tests and procedures which included body temperature: 102 on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Headache; pain in left arm; This is a spontaneous report from a contactable consumer (patient himself). A 45-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL 3247), via an unspecified route of administration in left arm on 27Jan2021 11:15 AM at single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications included PROBIOTIC and colecalciferol (VITAMIN D). The patient have not been tested for COVID-19 since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 12:00 PM, the patient experienced headache and pain in left arm. The patient did not receive treatment for the adverse events. The events were considered as non-serious by the consumer. The outcome of the events was recovered on an unspecified date in 2021.